March 23 (Reuters) - Pharmaust Ltd PAA.AX :* EPICHEM THROUGH UNIT ENTERED LICENSING AGREEMENT WITH ILLINOIS-BASED THERMAQUATICA* AGREEMENT TO DEVELOP AND PROMOTE DISRUPTIVE WASTE...
Feb 15 (Reuters) - Pharmaust Ltd PAA.AX :* UPDATE ON PHASE IIB CLINICAL TRIAL RECRUITMENT* RECRUITMENT FOR PHASE IIB CLINICAL TRIAL HAS COMMENCED
Dec 22 (Reuters) - Pharmaust Ltd PAA.AX :* RECEIVES ETHICS APPROVALS TO COMMENCE PHASE IIB DOG CANCER TRIAL
Pharmaust Limited is an Australia-based clinical-stage pharmaceutical company. The Company is focused on developing therapeutics for cancer, neurodegenerative diseases and viral infections in humans and cancer for pet dogs. The Company's lead candidate, monepantel (MPL), is a small molecule drug primarily being developed as a safe and potent treatment for cancer. The MPL can also be used for neurodegenerative diseases such as Motor Neuron Disease, Parkinson's Disease, and Alzheimer's Disease. It has completed Phase I clinical trials with MPL in humans and dogs diagnosed with solid tumors. The Company has also initiated a preclinical program to screen its portfolio of aminoacetonitrile (AAD) compounds for anticancer activity.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Neutral | Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Sell | Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 109.50 | 111.00 | 108.82 | +1.150 | +1.06% | 1.08M | Sydney | |||
| 0.50 | 0.50 | 0.50 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 1.295 | 1.36 | 1.28 | -0.025 | -1.89% | 2.17M | Sydney | |||
| 0.665 | 0.67 | 0.655 | 0.000 | 0.00% | 18.28K | Sydney | |||
| 13.30 | 13.31 | 13.29 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 15.21 | 15.39 | 14.70 | +0.44 | +2.98% | 993.14K | Sydney | |||
| 5.46 | 5.55 | 5.44 | -0.10 | -1.80% | 3.29M | Sydney | |||
| 3.20 | 3.20 | 3.20 | +0.20 | +6.67% | 1.96K | Sydney | |||
| 0.675 | 0.77 | 0.57 | +0.135 | +25.00% | 1.02M | Sydney | |||
| 0.081 | 0.089 | 0.081 | -0.004 | -4.71% | 25.50M | Sydney | |||
| 0.022 | 0.023 | 0.022 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 5.11 | 5.11 | 5.11 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 0.69 | 0.70 | 0.67 | -0.01 | -1.42% | 138.02K | Sydney | |||
| 0.705 | 0.705 | 0.695 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 2.14 | 2.14 | 2.14 | 0.00 | 0.00% | 0.00 | Sydney |